Literature DB >> 18474659

Beneficial response to rituximab in a patient with haemolysis and refractory Felty syndrome.

A Salama, U Schneider, T Dörner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18474659     DOI： 10.1136/ard.2007.077966

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  [Rituximab for treatment of Felty’s syndrome].

Authors:  H Becker; H Appel; T Fassbinder; D Heitzmann; P Willeke; A M Jacobi
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372

2.  [Recommendations for use of rituximab in patients with rheumatoid arthritis].

Authors:  A Rubbert-Roth; G R Burmester; T Dörner; A Gause
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

3.  Kinetics of Rituximab Excretion into Urine and Peritoneal Fluid in Two Patients with Nephrotic Syndrome.

Authors:  Klaus Stahl; Michelle Duong; Anke Schwarz; A D Wagner; Hermann Haller; Mario Schiffer; Roland Jacobs
Journal:  Case Rep Nephrol       Date:  2017-01-24

4.  Targeted Therapy with Rituximab in Felty's Syndrome: A Case Report.

Authors:  Line Heylen; Daan Dierickx; Peter Vandenberghe; René Westhovens
Journal:  Open Rheumatol J       Date:  2012-11-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.